Cytori Therapeutics Inc - 48 Year Dividend History | CYTX

Historical dividend payout and yield for Cytori Therapeutics Inc (CYTX) since 1971. The current TTM dividend payout for Cytori Therapeutics Inc (CYTX) as of June 25, 2019 is $0.00. The current dividend yield for Cytori Therapeutics Inc as of June 25, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.005B $0.004B
Cytori Therapeutics, Inc. is discovering and developing proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue, also known as fat. The Company's preclinical investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders, and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose stem and regenerative cells, Cytori has developed its proprietary Celution System to isolate and concentrate a patient's own stem and regenerative cells in about an hour. This system will dramatically improve the speed in which personalized cell-based therapies can be delivered to patients.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $112.734B 12.75
Gilead Sciences (GILD) United States $87.764B 10.66
Bio-Techne Corp (TECH) United States $7.796B 53.19